文献速递头颈部肿瘤放疗放疗物理与技术

预测头颈部癌症计划剂量与累积剂量临床相关偏差的模型

Predictive Models to Determine Clinically Relevant Deviations in Delivered Dose for Head and Neck Cancer.
PubMed 文献 · Pract Radiat Oncol · 2019-03-02

本研究回顾性分析100例头颈部癌症患者,通过形变配准将计划CT轮廓映射至每次锥形束CT并计算剂量以累积剂量,建立阈值偏差模型预测分次放疗中是否需要重新计划;该模型在另一机构52例患者中验证,预测颌下腺需重新计划的敏感度为100%、特异度为98.0%。

要点

  • 100例头颈部癌症患者回顾性评估,剂量累积于10个器官。
  • 颌下腺在分次15时递送剂量较计划高至少3.5 Gy则需重新计划,模型特异度98.7%。
  • 独立验证队列52例中该模型预测颌下腺需重新计划的敏感度100%、特异度98.0%。

核心结论

  • 确定了分次15(总30至35分次)时预测颌下腺需重新计划的治疗中阈值偏差。

研究设计与样本

  • 回顾性评估100例头颈部癌症患者,将计划CT轮廓经形变配准映射至每次锥形束CT并计算剂量。
  • 对均值剂量约束结构取各分次均值剂量平均以近似累积剂量,对最大剂量约束结构取每日最大剂量求和以近似累积剂量。
  • 预测模型应用于另一机构治疗的52例患者进行独立评估。

主要发现

  • 100例患者中剂量累积于10个器官。
  • 颌下腺在分次15时递送剂量较计划高至少3.5 Gy则需重新计划,模型预测特异度98.7%。
  • 独立评估队列中该模型预测颌下腺需重新计划的敏感度100%、特异度98.0%。
  • 口腔、中间临床靶区、左侧腮腺和咽下缩肌患者组各有一例在放疗结束时超过阈值偏差。
  • 在总30至35分次中的分次15时,左侧腮腺、咽下缩肌和中间临床靶区的剂量偏差分别为3.1 Gy、5.9 Gy和4.8 Gy。

关键数值与推荐

  • 颌下腺:分次15时递送剂量较计划高至少3.5 Gy需重新计划,预测敏感度100%、特异度98.7%。
  • 独立验证队列中该模型预测颌下腺需重新计划的敏感度100%、特异度98.0%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to improve the understanding of deviations between planned and accumulated doses and to establish metrics to predict clinically significant dosimetric deviations midway through treatment to evaluate the potential need to re-plan during fractionated radiation therapy (RT). METHODS AND MATERIALS: A total of 100 patients with head and neck cancer were retrospectively evaluated. Contours were mapped from the planning computed tomography (CT) scan to each fraction cone beam CT via deformable image registration. The dose was calculated on each cone beam CT and evaluated based on the mapped contours. The mean dose at each fraction was averaged to approximate the accumulated dose for structures with mean dose constraints, and the daily maximum dose was summed to approximate the accumulated dose for structures with maximum dose constraints. A threshold deviation value was calculated to predict for patients needing midtreatment re-planning. This predictive model was applied to 52 patients treated at a separate institution. RESULTS: Dose was accumulated on 10 organs over 100 patients. To generate a threshold deviation that predicted the need to re-plan with 100% sensitivity, the submandibular glands required re-planning if the delivered dose was at least 3.5 Gy higher than planned by fraction 15. This model predicts the need to re-plan the submandibular glands with 98.7% specificity. In the independent evaluation cohort, this model predicts the need to re-plan the submandibular glands with 100% sensitivity and 98.0% specificity. The oral cavity, intermediate clinical target volume, left parotid, and inferior constrictor patient groups each had 1 patient who exceeded the threshold deviation by the end of RT. By fraction 15 of 30 to 35 total fractions, the left parotid gland, inferior constrictor, and intermediate clinical target volume had a dose deviation of 3.1 Gy, 5.9 Gy, and 4.8 Gy, respectively. When a deformable image registration failure was observed, the dose deviation exceeded the threshold for at least 1 organ, demonstrating that an automated deformable image registration-based dose assessment process could be developed with user evaluation for cases that result in dose deviations. CONCLUSIONS: A midtreatment threshold deviation was determined to predict the need to replan for the submandibular glands by fraction 15 of 30 to 35 total fractions of RT.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. McCulloch MM, Lee C, Rosen BS, et al. Predictive Models to Determine Clinically Relevant Deviations in Delivered Dose for Head and Neck Cancer. Pract Radiat Oncol. 2019. PMID: 30836190. doi:10.1016/j.prro.2019.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。